scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0022-3476(87)80569-3 |
P698 | PubMed publication ID | 3559816 |
P2093 | author name string | M J Boutroy | |
P Vert | |||
A Bairam | |||
Y Badonnel | |||
P2860 | cites work | Pharmacokinetic aspects of theophylline in premature newborns | Q34743357 |
Structural and functional development of the nephron | Q40156890 | ||
Glomerular tubular balance in preterm and fullterm infants | Q40156903 | ||
Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant | Q41636052 | ||
Developmental aspects of theophylline metabolism in premature infants. | Q52281973 | ||
Postnatal development of renal function in pre-term and full-term infants | Q70151128 | ||
Pharmacokinetic aspects of caffeine in premature infants with apnoea | Q70399211 | ||
On the mechanisms of renal sodium handling in newborn infants | Q71139079 | ||
Plasma theophylline and caffeine and plasma clearance of theophylline during theophylline treatment in the first year of life | Q71763108 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | preterm infant | Q45051448 |
P304 | page(s) | 636-639 | |
P577 | publication date | 1987-04-01 | |
P1433 | published in | The Journal of Pediatrics | Q7743611 |
P1476 | title | Theophylline versus caffeine: comparative effects in treatment of idiopathic apnea in the preterm infant | |
P478 | volume | 110 |
Q34153141 | Apnea of prematurity: pathogenesis and management strategies |
Q32060945 | Caffeine citrate: a review of its use in apnoea of prematurity |
Q34029994 | Caffeine for the management of apnea in preterm infants |
Q35066892 | Caffeine or theophylline for neonatal apnoea? |
Q26777204 | Caffeine therapy in preterm infants |
Q24240967 | Caffeine versus theophylline for apnea in preterm infants |
Q89462491 | Caffeine: an evidence-based success story in VLBW pharmacotherapy |
Q74245819 | Comparative effects of theophylline and caffeine on respiratory function of prematurely born infants |
Q47364059 | Consequences of maternal omega-3 polyunsaturated fatty acid supplementation on respiratory function in rat pups. |
Q46402459 | Differential diagnosis of apneas in preterm infants |
Q47635407 | Inhibitory respiratory responses to progesterone and allopregnanolone in newborn rats chronically treated with caffeine |
Q36934528 | Olfactory stimulation by vanillin prevents apnea in premature newborn infants |
Q37647027 | Pathophysiology of apnoea in preterm infants |
Q34058622 | Pharmacological rationale for the clinical use of caffeine |
Q36769620 | Purines, the carotid body and respiration. |
Q34086090 | Risks and benefits of therapies for apnoea in premature infants |
Q35074315 | Treatment of apnea of prematurity |
Q38176575 | Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity. |
Q77365650 | [Treatment of apnea in prematurity] |